Concepedia

Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011)

Ronald N. Jones, Hélio S. Sader, Robert K. Flamm

Diagnostic Microbiology and Infectious Disease · 2013 · 118 citations · 18 references

DOI

Concepts

References

18

Randomized, Double-Blind Comparison of Once-Weekly Dalbavancin versus Twice-Daily Linezolid Therapy for the Treatment of Complicated Skin and Skin Structure Infections

L. E. Jauregui, S. Babazadeh, Elyse Seltzer et al. · Clinical Infectious Diseases · 2005 · 310 citations · Full text

, , +17

Once-Weekly Dalbavancin versus Standard-of-Care Antimicrobial Regimens for Treatment of Skin and Soft-Tissue Infections

Elyse Seltzer, MaryBeth Dorr, Beth P. Goldstein et al. · Clinical Infectious Diseases · 2003 · 233 citations

, , +17

Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates

Jennifer M Streit, Thomas R. Fritsche, Hélio S. Sader et al. · Diagnostic Microbiology and Infectious Disease · 2003 · 142 citations

, , +11

In Vivo Pharmacodynamic Activity of the Glycopeptide Dalbavancin

David R. Andes, William A. Craig · Antimicrobial Agents and Chemotherapy · 2007 · 115 citations

, , +15

Population Pharmacokinetic Analysis of Dalbavancin, a Novel Lipoglycopeptide

Mary Buckwalter, James A. Dowell · The Journal of Clinical Pharmacology · 2005 · 107 citations

, , +14